Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab in the FAERS Database

Ibrahim Touffaha, Elizabeth Ablah, Hayrettin Okut, Gretchen Homan

Open source

DOI: 10.17161/kjm.vol19.25544
Published: 2026-08-18
Container: Kansas Journal of Medicine
Publisher: The University of Kansas
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.17161/kjm.vol19.25544,
  title = {Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab in the FAERS Database},
  author = {Ibrahim Touffaha and Elizabeth Ablah and Hayrettin Okut and Gretchen Homan},
  year = {2026},
  journal = {Kansas Journal of Medicine},
  doi = {10.17161/kjm.vol19.25544},
  url = {https://doi.org/10.17161/kjm.vol19.25544}
}

RIS

TY  - JOUR
TI  - Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab in the FAERS Database
AU  - Ibrahim Touffaha
AU  - Elizabeth Ablah
AU  - Hayrettin Okut
AU  - Gretchen Homan
PY  - 2026
JO  - Kansas Journal of Medicine
DO  - 10.17161/kjm.vol19.25544
UR  - https://doi.org/10.17161/kjm.vol19.25544
ER  -

APA

Touffaha, I., Ablah, E., Okut, H., & Homan, G. (2026). Comparative Analysis of Reported Adverse Events with Nirsevimab and Palivizumab in the FAERS Database. Kansas Journal of Medicine. https://doi.org/10.17161/kjm.vol19.25544

Source records

crossref · retrieved 2026-09-27T06:26:22.958Z